In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Anthem acquires Cigna for $48bn; blocked; withdrawn

Executive Summary

Anthem Inc. paid $48bn for fellow public insurance company Cigna Corp. Anthem is issuing 0.5152 shares and paying $103.40 in cash for each Cigna share, equating to a $187.45 per-share price (a 40% premium based on the ten-day average prior to rumors in late May 2015 that Cigna's rival Humana Inc. was up for sale; Aetna Inc. ended up acquiring Humana in a $35bn deal in early July 2015). Post-transaction, Anthem shareholders will own 67% of the entity, and Cigna the rest.
Deal Industry
  • Pharmaceuticals
  • Services
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register